Margalit Efrati

519 total citations
25 papers, 406 citations indexed

About

Margalit Efrati is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Margalit Efrati has authored 25 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Margalit Efrati's work include Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (5 papers). Margalit Efrati is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (5 papers). Margalit Efrati collaborates with scholars based in Israel, Germany and United States. Margalit Efrati's co-authors include Yona Keisari, I. Kelson, Michael Schmidt, Tomer Cooks, L. Arazi, Rachel Ehrlich, Viktor Umansky, Ilan Hochman, Isaac P. Witz and Allen D. Roses and has published in prestigious journals such as Cancer, British Journal of Cancer and Journal of Bone and Mineral Research.

In The Last Decade

Margalit Efrati

25 papers receiving 392 citations

Peers

Margalit Efrati
A. Fontana Switzerland
Yuquan Shi Switzerland
Valérie Buard France
Eszter Persa Hungary
Yaqin Zhao China
Nikolai Jaschke Germany
Herbert Archer United States
Fujun Han China
Hikaru Watarai Japan
Enikő Kis Hungary
A. Fontana Switzerland
Margalit Efrati
Citations per year, relative to Margalit Efrati Margalit Efrati (= 1×) peers A. Fontana

Countries citing papers authored by Margalit Efrati

Since Specialization
Citations

This map shows the geographic impact of Margalit Efrati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margalit Efrati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margalit Efrati more than expected).

Fields of papers citing papers by Margalit Efrati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margalit Efrati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margalit Efrati. The network helps show where Margalit Efrati may publish in the future.

Co-authorship network of co-authors of Margalit Efrati

This figure shows the co-authorship network connecting the top 25 collaborators of Margalit Efrati. A scholar is included among the top collaborators of Margalit Efrati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margalit Efrati. Margalit Efrati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Efrati, Margalit, et al.. (2022). Diffusing Alpha-Emitters Radiation Therapy Promotes a Proimmunogenic Tumor Microenvironment and Synergizes With Programmed Cell Death Protein 1 Blockade. International Journal of Radiation Oncology*Biology*Physics. 115(3). 707–718. 14 indexed citations
2.
Efrati, Margalit, et al.. (2022). 428 Diffusing alpha-emitters radiation therapy promotes a pro-immunogenic tumor microenvironment and synergizes with PD-1 blockade. Regular and Young Investigator Award Abstracts. A449–A449. 2 indexed citations
3.
4.
Cohen, Adi, Margalit Efrati, Michael Schmidt, et al.. (2019). Combining alpha radiation-based brachytherapy with immunomodulators promotes complete tumor regression in mice via tumor-specific long-term immune response. Cancer Immunology Immunotherapy. 68(12). 1949–1958. 31 indexed citations
5.
Schmidt, Michael, Margalit Efrati, Ilan Hochman, et al.. (2016). Inhibition of mouse breast adenocarcinoma growth by ablation with intratumoral alpha-irradiation combined with inhibitors of immunosuppression and CpG. Cancer Immunology Immunotherapy. 65(10). 1149–1158. 32 indexed citations
6.
Schmidt, Michael, Tomer Cooks, Margalit Efrati, et al.. (2014). Ablation of experimental colon cancer by intratumoral224Radium-loaded wires is mediated by alpha particles released from atoms which spread in the tumor and can be augmented by chemotherapy. International Journal of Radiation Biology. 91(2). 179–186. 18 indexed citations
7.
Hochman, Ilan, Margalit Efrati, Michael Schmidt, et al.. (2014). Tumor ablation by intratumoral Ra-224-loaded wires induces anti-tumor immunity against experimental metastatic tumors. Cancer Immunology Immunotherapy. 64(2). 191–199. 33 indexed citations
8.
Arazi, L., Margalit Efrati, Tomer Cooks, et al.. (2012). ComparativeIn VitroMicrodosimetric Study of Murine- and Human-Derived Cancer Cells Exposed to Alpha Particles. Radiation Research. 177(3). 280–287. 16 indexed citations
9.
Cooks, Tomer, Michael Schmidt, L. Arazi, et al.. (2011). Local control of experimental malignant pancreatic tumors by treatment with a combination of chemotherapy and intratumoral 224Radium-loaded wires releasing alpha-emitting atoms. Translational research. 159(1). 32–41. 32 indexed citations
10.
11.
Meilin, Sigal, et al.. (2003). Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice. Neurobiology of Disease. 12(1). 56–64. 41 indexed citations
12.
Efrati, Margalit, et al.. (2000). Secretion of the amyloid precursor protein is elevated isoform specifically by apolipoprotein E4. PubMed. 59. 163–169. 6 indexed citations
13.
Efrati, Margalit, et al.. (1995). Monoclonal antibodies recognize antigen expressed by osteoblasts. Journal of Bone and Mineral Research. 10(10). 1496–1503. 12 indexed citations
14.
Yron, Ilana, et al.. (1988). Comparison of NK Activity in Mouse Spleen and Peripheral Blood Lymphocytes. Immunobiology. 177(4-5). 449–459. 6 indexed citations
15.
Ehrlich, Rachel, et al.. (1986). Marker and function analysis of natural killer and alloreactive T cells during early stages of dimethylbenzanthracene carcinogenesis. The immunity system during the precancer period.. PubMed. 5(6). 305–16. 4 indexed citations
16.
Yron, Ilana, et al.. (1985). The analysis of measurements of murine natural killer cell activity. Journal of Immunological Methods. 79(1). 109–121. 1 indexed citations
17.
Witz, Isaac P., Margalit Efrati, Rachel Ehrlich, et al.. (1985). Natural Defense and Chemical Carcinogenesis. Hämatologie und Bluttransfusion. 29. 492–498. 2 indexed citations
18.
Ehrlich, Rachel, et al.. (1983). Natural Cellular Defense Activities Against Tumors — Cytostasis and NK Activity. Hämatologie und Bluttransfusion. 28. 470–471. 1 indexed citations
19.
Ehrlich, Rachel, et al.. (1983). Natural host defence during oncogenesis. NK activity and dimethylbenzanthracene carcinogenesis. International Journal of Cancer. 31(1). 67–73. 27 indexed citations
20.
Ehrlich, Rachel, et al.. (1980). NATURAL CELLULAR REACTIVITIES MEDIATED BY SPLENOCYTES FROM MICE BEARING THREE TYPES OF PRIMARY TUMOR. International Journal of Cancer. 26(3). 315–323. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Fontana Breakdown of academic impact, for papers by Yuquan Shi Breakdown of academic impact, for papers by Valérie Buard Breakdown of academic impact, for papers by Eszter Persa Breakdown of academic impact, for papers by Yaqin Zhao Breakdown of academic impact, for papers by Nikolai Jaschke Breakdown of academic impact, for papers by Herbert Archer Breakdown of academic impact, for papers by Fujun Han Breakdown of academic impact, for papers by Hikaru Watarai Breakdown of academic impact, for papers by Enikő Kis
Rankless by CCL
2026